Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make

Business

His comments come after Merck officially opened its new 120,000-square-foot research facility in the Greater Philadelphia area.

Read the original report.

Articles You May Like

Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
What the Democratic midterms sweep changes for U.S.-China relations
Qualcomm stock drops 7% on weak earnings forecast as memory shortage weighs on smartphone sales
McDonald’s earnings beat, but traffic to its U.S. restaurants falls
Judge Blocks Part Of Trump’s Medicaid Work Rule But Much Will Continue

Leave a Reply

Your email address will not be published. Required fields are marked *